Summaries of the Section H (HML) update

Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.

The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule. 

The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month. 

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

17 September 2026 - preview of changes for October 2026

Pharmaceutical

Change

Aflibercept (Eylea) inj 40 mg per ml, 0.1 ml vial

new Pharmacode listing (p’code 2737876)

Amino acid formula (without phenylalanine) (Phlexy 10) tab 8.33 mg

to be delisted 1 December 2026

Amino acid formula (without phenylalanine) (Easiphen Liquid) liquid 6.7 g protein, 5.1 g carbohydrate and 2 g fat per 100 ml, 250 ml carton

to be delisted 1 March 2027

Aripiprazole (Aripiprazole Sandoz) tab 5 mg, 10 mg, 15 mg, 20 mg and 30 mg 

price decrease and addition of PSS

Betahistine dihydrochloride (Serc) tab 16 mg

new Pharmacode listing (p’code 2712393)

Candesartan cilexetil (Candesarten Viatris) tab 32 mg

new pack size listing (p’code 2735164)

Cefotaxime (DBL Cefotaxime) inj 1 g vial

price increase and addition of PSS

Cyclopentolate hydrochloride

Brand change

  • Minims Cyclopentolate eye drops 1%, single dose, 20 dose – new listing and addition of PSS (p’code 2603160)
  • Cyclogyl eye drops 1%, 15 ml to be delisted 1 March 2027

Dapsone tab 50 mg and 100 mg

Brand change

Dapsomed – new listing and addition of PSS

  • Tab 50 mg (p’code 2734621)
  • Tab 100 mg (p’code 2736276)

Dapsone and Dapsone (Rising) tab 25 mg and Dapsone tab 100 mg to be delisted 1 March 2027

Diazepam (Arrow-Diazepam) tab 2 mg and 5 mg

price increase and addition of PSS

Dimethicone crm 10% pump bottle

Brand change

  • EVARA Dimethicone 10% Cream, 480 g – new listing and addition of PSS (p’code 2732904)
  • healthE Dimethicone 10%, 460 g to be delisted 1 March 2027

Disopyramide (Rythmodan (Cheplapharm)) cap 100 mg

new listing (p’code 2737221) and amended chemical name

Entecavir tab 0.5 mg

Brand change

  • Entecavir Sandoz – new listing and addition of PSS (p’code 2549301)
  • Entecavir (Rex) to be delisted 1 March 2027

Exemestane (Pfizer Exemestane) tab 25 mg

price increase and addition of PSS

Ezetimibe with simvastatin

new listing

  • Tab 10 mg with simvastatin 10 mg (Vytorin) (p’code 2735539)
  • Tab 10 mg with simvastatin 20 mg (Ezetimibe Simvastatin Viatris) (p’code 2737205)
  • Tab 10 mg with simvastatin 40 mg (Ascend) (p’code 2737884)

Fluconazole (APO Health Fluconazole One) cap 150 mg

new listing (p’code 2735016)

Glycerol trioleate (GTO Oil) liquid, bottle

delisted 1 October 2026

Glycomacropeptide and amino acid contains some phenylalanine (PKU GMPro LQ) liquid (neutral),10 g protein, 8.5 g carbohydrate per 250 ml carton

to be delisted 1 December 2026

Icatibant (Icatibant Lupin) inj 10 mg per ml, 3 ml prefilled syringe 

amended restriction criteria

Influenza vaccine (Influvac Tetra (2026 formulation)) inj 60 mcg in 0.5 ml syringe (quadrivalent vaccine)

amended restriction criteria

Latanoprost with timolol (Arrow – Lattim) eye drops 0.005% with timolol 0.5%, 2.5 ml 

price increase and addition of PSS

Loratadine (Haylor Syrup) oral liq 1 mg per ml, 100 ml

price increase

Mercaptopurine (Mercaptopurine (Sterimax)) tab 50 mg

new listing (p’code 2737310)

Methylphenidate hydrochloride (Rubifen LA)

new listing

  • Cap modified-release 10 mg (p’code 2735075)
  • Cap modified-release 20 mg (p’code 2735083)
  • Cap modified-release 30 mg (p’code 2735091)
  • Cap modified-release 40 mg (p’code 2735105)
  • Cap modified-release 60 mg (p’code 2735113)

Methylphenidate hydrochloride

  • Tab extended-release 18 mg, 27 mg, 36 mg and 54 mg (Concerta and Methylphenidate ER – Teva)
  • Tab immediate-release 5 mg, 10 mg and 20 mg (Rubifen)
  • Tab immediate-release 10 mg (Ritalin)
  • Tab modified-release 18 mg, 27 mg, 36 mg and 54 mg (Methylphenidate Sandoz XR)
  • Tab sustained-release 20 mg (Rubifen SR)
  • Cap modified-release 10 mg, 20 mg, 30 mg and 40 mg (Ritalin LA)
  • Cap modified-release 10 mg, 20 mg, 30 mg, 40 mg and 60 mg (Rubifen LA)

amended restriction criteria

Nifedipine (Nifedipine Extended Release (Viatris)) tab long-acting 60 mg 

new listing (p’code 2736039)

Olanzapine (Zyprexa Zydis) tab orodispersible 5 mg

new listing (p’code 2737736)

Omeprazole (Omeprazole Teva) cap 10 mg, 20 mg and 40 mg

price increase and addition of PSS

Omeprazole cap 10 mg (Omeprazole actavis 10), cap 20 mg (Omeprazole actavis 20) and cap 40 mg (Omeprazole actavis 40)

to be delisted 1 March 2027

Oxycodone hydrochloride (Oxycodone Amneal) tab immediate-release 5 mg, 10 mg and 20 mg

price increase

Pegaspargase (Oncaspar) inj 750 iu per ml, 5 ml vial

amended brand name

Pegylated interferon alfa-2a (Pegasys S29 (ANZ)) inj 180 mcg prefilled syringe 

new listing (p’code 2737728)

Pirfenidone (Pirfenidone Sandoz) tab 801 mg

new Pharmacode listing (p’code 2735652)

Povidone-iodine (Betadine) oint 10%, 65 g

new Pharmacode listing (p’code 2730618)

Prazosin (APO-Prazosin) tab 1 mg, 2 mg and 5 mg

price increase and amended brand name

Progesterone (Utrogestan) cap 100 mg

to be delisted 1 February 2027

Raltegravir potassium

new Pharmacode listing

  • Tab 400 mg (Isentress) (p’code 2736004)
  • Tab 600 mg (Isentress HD) (p’code 2736012)

Ribociclib (Kisqali) tab 200 mg

  • 21 pack (p’code 2701340)
  • 42 pack (p’code 2701359)
  • 63 pack (p’code 2701367)

to be delisted 1 March 2027

Rifampicin (Rifadin) cap 150 mg and oral liq 100 mg per 5 ml, 60 ml

price increase and addition of PSS

Rifampicin (Rifadin) cap 300 mg

addition of PSS

Risperidone

new listing

  • Tab 1 mg (Risperidone Sandoz) (p’code 2693151)
  • Tab 3 mg (Relonchem) (p’code 2737868)

Rosuvastatin (Rosuvastatin Viatris, Rosuvastatin – Sandoz and Rosuvastatin Mylan) tab 5 mg, 10 mg, 20 mg and 40 mg

removal of restriction criteria

Rosuvastatin (Rosuvastatin Viatris) tab 5 mg, 10 mg, 20 mg and 40 mg

price decrease and addition of PSS

Rosuvastatin (Rosuvastatin – Sandoz and Rosuvastatin Mylan) tab 5 mg, 10 mg, 20 mg and 40 mg

to be delisted 1 March 2027

Roxithromycin (Arrow-Roxithromycin) tab 150 mg and 300 mg

price increase and addition of PSS

Sildenafil (Sildenafil (Crescent)) tab 25 mg

new listing (p’code 2736020)

Sumatriptan (Sumatriptan Viatris)

new listing

  • Tab 50 mg (p’code 2733862)
  • Tab 100 mg (p’code 2733870)

Thiotepa (Tepadina) inj 15 mg vial and 100 ml vial

price decrease and addition of PSS

Tropicamide

Brand change

Minims Tropicamide – new listing and
addition of PSS

  • Eye drops 0.5%, single dose, 20 dose (p’code 307300)
  • Eye drops 1%, single dose, 20 dose (p’code 307319)

Mydriacyl eye drops 0.5% and eye drops 1%, 15 ml to be delisted 1 March 2027

Find previous months' summaries